Transplantation: the role of immunohematologic services.
The role of the immunohematologic services in transplantation is described.  Provision of blood products for transplantation is necessary for prevention of alloimmunization or graft rejection, graft versus host disease secondary to transfusion, and transfusion-transmissible diseases in an immunosuppressed patient while avoiding unnecessary donor exposure. Requirements differ with different types of transplants.  The transfusion service needs to provide products according to the specific needs of the transplant recipient and establish protocols for each different transplantation program.
Myers
J A
JA
Clinical Laboratories, University of California Medical Center, Los Angeles 90024.
D001781:Blood Component Removal; D001789:Blood Group Antigens; D001803:Blood Transfusion / Q000379:methods; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000517:prevention & control; D006405:Hematology; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods; D007755:Laboratories, Hospital; D016377:Organ Transplantation / Q000009:adverse effects / Q000379:methods; D014019:Tissue Donors